Risk factors for complications following sacral neuromodulation for faecal incontinence: Long‐term follow‐up
Colorectal Disease · 2024
DOI: 10.1111/codi.17092 ↗Kurz gefasst
Fachartikel in der Zeitschrift Colorectal Disease, 2024. Verfasst von Rachel Gefen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Ellen Leifer Shulman and Steven Shulman Digestive Disease Centre, Cleveland Clinic Florida, Weston, Florida, USA. Hauptthemen laut MEDLINE: Fecal Incontinence, Postoperative Complications, Electric Stimulation Therapy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Inkontinenz
Abstract (Originalsprache)
Aim
Sacral neuromodulation (SNM) has become a standard surgical treatment for faecal incontinence (FI). Prior studies have reported various adverse events of SNM, including suboptimal therapeutic response, infection, pain, haematoma, and potential need for redo SNM. The aim of this study was to identify the risk factors associated with long‐term complications of SNM.
Method
This retrospective cohort reviewed patients who underwent two‐stage SNM for FI at our institution between 2011–2021. Preoperative baseline characteristics and follow‐up were obtained from the medical record and/or by telephone interview. Management and outcome of each postoperative event were evaluated by univariate and multivariate regression analyses.
Results
A total of 291 patients (85.2% female) were included in this study. Postoperative complications were recorded in 219 (75.2%) patients and 154 (52.9%) patients required surgical intervention to treat complications. The most common postoperative event was loss of efficacy (46.4%). Other common adverse events were problems at the implant site (pain, infection, etc.) in 16.5% and pain during stimulation in 11.7%. Previous vaginal delivery (OR 2.74, p = 0.003) and anal surgery (OR = 2.46, p = 0.039) were independent predictors for complications. Previous colorectal (OR = 2.04, p = 0.026) and anal (OR = 1.98, p = 0.022) surgery and history of irritable bowel syndrome (IBS) (OR = 3.49, p = 0.003) were independent predictors for loss of efficacy.
Conclusion
Postoperative adverse events are frequently recorded after SNM. Loss of efficacy is the most common. Previous colorectal or anal surgery, vaginal delivery, and IBS are independent risk factors for complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Ellen Leifer Shulman and Steven Shulman Digestive Disease Centre, Cleveland Clinic Florida, Weston, Florida, USA.
- Department of General Surgery, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
- Department of Surgery and Transplantation, Sheba Medical Centre, Ramat-Gan, Israel.
- Colorectal Surgery Unit, General Surgery Department, Mansoura University Hospitals, Mansoura, Egypt.
ORCID-Profile: Rachel Gefen, Sameh Hany Emile, Steven Wexner
Zitieren
APA
Gefen, R., Strassmann, V., Stefano Hernandez, F., Garoufalia, Z., Horesh, N., Emile, S. H., Da Silva, G., & Wexner, S. (2024). Risk factors for complications following sacral neuromodulation for faecal incontinence: Long‐term follow‐up. Colorectal Disease. https://doi.org/10.1111/codi.17092
Vancouver
Gefen R, Strassmann V, Stefano Hernandez F, Garoufalia Z, Horesh N, Emile SH, et al. Risk factors for complications following sacral neuromodulation for faecal incontinence: Long‐term follow‐up. Colorectal Disease. 2024. doi:10.1111/codi.17092
BibTeX
@article{Gefen2024,
author = {Gefen, Rachel and Strassmann, Victor and Stefano Hernandez, Felice De and Garoufalia, Zoe and Horesh, Nir and Emile, Sameh Hany and Da Silva, Giovanna and Wexner, Steven},
title = {Risk factors for complications following sacral neuromodulation for faecal incontinence: Long‐term follow‐up},
journal = {Colorectal Disease},
year = {2024},
doi = {10.1111/codi.17092}
}
EUVIMED